<?xml version="1.0" encoding="UTF-8"?>
<!--generator='jetpack-15.8'-->
<!--Jetpack_Sitemap_Buffer_News_XMLWriter-->
<?xml-stylesheet type="text/xsl" href="//drbarrydworkin.com/news-sitemap.xsl"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd">
 <url>
  <loc>https://drbarrydworkin.com/health-headlines/medicine-health-headlines/infectious-disease-medicine-health-headlines-health-headlines/outaouais-public-health-unit-investigating-cases-of-legionnaires-disease-in-aylmer-que/</loc>
  <lastmod>2026-07-18T16:40:42Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dr. Barry Dworkin</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Outaouais public health unit investigating cases of Legionnaires’ disease in Aylmer, Que.</news:title>
   <news:publication_date>2026-07-17T16:39:13Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://drbarrydworkin.com/health-headlines/medicine-health-headlines/neurology-medicine-health-headlines-health-headlines/this-new-alzheimers-drug-targets-a-different-brain-protein-and-requires-further-evaluation-in-the-research-timeline-further-studies-required-including-phase-3-data/</loc>
  <lastmod>2026-07-18T16:39:02Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dr. Barry Dworkin</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>This new Alzheimer’s drug targets a different brain protein, and requires further evaluation in the research timeline. Further studies required including phase 3 data.</news:title>
   <news:publication_date>2026-07-16T16:26:14Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
</urlset>
